CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention
Abroad (travel likely)RecruitingPHASE4
Conditions
ACS - Acute Coronary Syndrome · CYP2C19 Polymorphism
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China
Contact: Principal Investigator (Cai De Jin, MD)Ran Zun Zhao, MD (Sub-investigator)
Study leads
Cai De Jin
Principal Investigator
Zunyi Medical College